0001209191-15-056014.txt : 20150624
0001209191-15-056014.hdr.sgml : 20150624
20150624182011
ACCESSION NUMBER: 0001209191-15-056014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150623
FILED AS OF DATE: 20150624
DATE AS OF CHANGE: 20150624
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MITCHELL W THOMAS
CENTRAL INDEX KEY: 0001214352
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 15950190
MAIL ADDRESS:
STREET 1: 48030 PASO TIEMPO LN
CITY: LA QUINTA
STATE: CA
ZIP: 92253
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-23
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001214352
MITCHELL W THOMAS
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2015-06-23
4
M
0
15000
6.66
A
16000
D
Common Stock
2015-06-23
4
S
0
15000
49.35
D
1000
D
Non-qualified Stock Option
6.66
2015-06-23
4
M
0
15000
6.66
D
2022-05-23
Common Stock
15000
0
D
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
The option was granted May 23, 2012 and vested in 12 equal monthly installments beginning June 23, 2012.
/s/Darin Lippoldt, attorney-in-fact
2015-06-24